Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Acute Promyelocytic Leukemia

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Acute Promyelocytic Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agranoff, AB; Betts, JC; Nabel, GJ; Shayman, JA1
Kan, CC; Kolesnick, RN1

Other Studies

2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Acute Promyelocytic Leukemia

ArticleYear
Dissociation of endogenous cellular ceramide from NF-kappa B activation.
    The Journal of biological chemistry, 1994, Mar-18, Volume: 269, Issue:11

    Topics: Antineoplastic Agents; Cell Line; Ceramides; Chloramphenicol O-Acetyltransferase; Genetic Vectors; HIV; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Leukemia, T-Cell; Morpholines; NF-kappa B; Tetradecanoylphorbol Acetate; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1994
A synthetic ceramide analog, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, selectively inhibits adherence during macrophage differentiation of human leukemia cells.
    The Journal of biological chemistry, 1992, May-15, Volume: 267, Issue:14

    Topics: Antineoplastic Agents; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Ceramides; Glycosphingolipids; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Macrophages; Morpholines; Tetradecanoylphorbol Acetate

1992